SlotmanB, Faivre-FinnC, KramerG, RankinE, SneeM, HattonM, PostmusP, ColletteL, MusatE, SenanS; EORTC Radiation Oncology Group and Lung Cancer Group. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med, 2007; 357(7):664-672.
5.
HowlettP, BrownC, HeldermanT, et al.Ebola virus disease complicated by late-onset encephalitis and polyarthritis, Sierra Leone [letter]. Emerg Infect Dis, 2016; 22(1). http://dx.doi.org/10.3201/eid2201.151212. Accessed November4, 2015.
6.
BwakaMA, BonnetMJ, CalainP, et al.Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis, 1999; 179(Suppl 1):S1-S7.
7.
BauschDG, TownerJS, DowellSF, et al.Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis, 2007; 196(Suppl 2):S142-S147.
8.
DeenGF, KnustB, BroutetN, et al.Ebola RNA persistence in semen of Ebola virus disease survivors—preliminary report. N Engl J Med, 2015Oct14. http://www.nejm.org/doi/full/10.1056/NEJMoa1511410. Accessed November4, 2015.
9.
QiuX, AudetJ, WongG, et al.Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb. Sci Rep, 2013; 3:3365.
10.
QiuX, WongG, AudetJ, et al.Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature, 2014; 514(7520):47-53.
11.
KugelmanJR, Kugelman-TonosJ, LadnerJT, et al.Emergence of Ebola virus escape variants in infected nonhuman primates treated with the MB-003 antibody cocktail. Cell Rep, 2015; 12(12):2111-2120.